Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio 43210, USA.
Microcirculation. 2012 Apr;19(3):215-23. doi: 10.1111/j.1549-8719.2011.00154.x.
MicroRNAs are small non-coding RNAs implicated mainly in post-transcriptional gene silencing by interacting with the untranslated region of the transcript. miR-210 represents major hypoxia-inducible miRs, also known as hypoxamirs, which is ubiquitously expressed in a wide range of cells, serving versatile functions. This review article summarizes the current progress on biogenesis of miR-210 and its physiological roles including arrest of cell proliferation, repression of mitochondrial respiration, arrest of DNA repair, vascular biology, and angiogenesis. Given the fact that miR-210 is aberrantly expressed in a number of diseases such as tumor progression, myocardial infarction and cutaneous ischemic wounds, miR-210 could serve as an excellent candidate for prognostic purposes and therapeutic intervention. With the advancement of computational prediction, high-throughput target validation methodology, sequencing, proteomic analysis, and microarray, it is anticipated that more down-stream targets of miR-210 and its associated biological consequences under hypoxia will be unveiled establishing miR-210 as a major hub in the biology of hypoxia-response.
MicroRNAs 是小的非编码 RNA,主要通过与转录本的非翻译区相互作用来参与转录后基因沉默。miR-210 是主要的缺氧诱导 miR,也称为 hypoxamirs,它在广泛的细胞中广泛表达,具有多种功能。这篇综述文章总结了 miR-210 的生物发生及其生理作用的最新进展,包括细胞增殖停滞、抑制线粒体呼吸、抑制 DNA 修复、血管生物学和血管生成。鉴于 miR-210 在许多疾病中异常表达,如肿瘤进展、心肌梗死和皮肤缺血性伤口,miR-210 可以作为预后和治疗干预的理想候选物。随着计算预测、高通量靶标验证方法、测序、蛋白质组学分析和微阵列的进步,可以预期将揭示更多 miR-210 的下游靶标及其在缺氧下的相关生物学后果,将 miR-210 确立为缺氧反应生物学的主要中心。